Medindia

X

'Crisis Management' PR Firm's Advice to Stem Cell Agency Laundered Through Law Firm to Avoid Scrutiny

Friday, February 8, 2008 General News J E 4
Advertisement




SANTA MONICA, Calif., Feb. 7 Documents detailing the California stem cell institute's involvement with a well-known "crisis management" public relations firm reveal an agency leadership worried about the state agency's image and committed to keeping PR advice secret by channeling it through an outside law firm, the Foundation for Taxpayer and Consumer Rights (FTCR) said today.



The stem cell institute, a public body formed to spend taxpayer-approved funds on research, paid the PR `agency with money funneled through the law firm, according to documents obtained by FTCR. The PR agency then apparently funneled its advice back through the law firm. The stem cell agency used the tactic to claim legal "confidentiality" on public relations strategies at a time of negative publicity over apparent conflicts of interest among board members.



In response to a Public Records Act request from FTCR, the stem cell agency released 54 pages of documents about its involvement with Rubenstein Associates, a New York public relations firm that describes its crisis management work as "a paradigm for the industry." Eight of the 54 pages, which seem to be about specific advice on handling the news media, were redacted because they are "documents exempt from disclosure on the grounds of attorney-client privilege and attorney work product," according to Tamar Pachter, general counsel for the stem cell agency.



"What they've done is launder the public relations advice to a state agency through their outside attorney, Remcho, Johansen & Purcell," said John M. Simpson, FTCR stem cell director. "Once again the leadership of the California Institute for Regenerative Medicine has shown concern about image, rather than substance, and a continued commitment to secrecy."



FTCR said CIRM should behave like the public state agency it is, not like a private corporation.



Read the documents here: http://www.consumerwatchdog.org/resources/Rubenstein.pdf



The documents show Rubenstein was approached last October for advice by James Harrison, of the Remcho firm, when articles appeared in the Australian Herald-Sun saying that a researcher in the stem cell laboratory run by incoming CIRM President Dr. Alan Trounson was under investigation for improprieties. There was no suggestion that Trounson was under investigation or involved in any wrongdoing.



Although he had been hired, Trounson had not assumed the CIRM post when the news of the investigation in Australia broke. Harrison approached Rubenstein at the request of Richard Murphy, interim CIRM president. He wrote Rubenstein Executive Vice President Patrick M. Smith seeking "to retain your firm to assist us with a response to the article and the questions it raises."



Under the deal worked out with Rubenstein, the PR firm received $10,000 for its advice on CIRM's behalf. However the agreement is technically with Remcho. The letter of agreement with Remcho says, "As part of our services, Rubenstein will provide Remcho, Johansen & Purcell with strategic public relations advice and guidance relative to general corporate matters affecting the California Institute for Regenerative Medicine... Rubenstein's work on this matter will be considered part of your work product and will be governed, to the extent permitted by law, by attorney/client privilege."



But the letter makes clear who is paying for the advice. It's taxpayer dollars: "Rubenstein recognizes and agrees that under no circumstances will Remcho, Johansen & Purcell be liable to pay fees to Rubenstein that it has not received from its client for such purposes, and agrees to look exclusively to your client for payment of any outstanding fee."



Presumably the eight redacted pages contained specific advice from Rubenstein Associates on how to handle
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Neuroscientists Offer Hope for Breast Cancer Patie...
S
Transcept Pharmaceuticals to Present at the 10th A...